Normal view MARC view ISBD view

Validation of fluorouracil metabolite analysis in excised tumor. Lability of anabolites. [electronic resource]

By:

Bading, J R

Contributor(s):

Producer: 20001019Description: 963-7 p. digitalISSN:

0006-2952

Subject(s):

Online resources:

Available from publisher's website

In: Biochemical pharmacology vol. 60

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

There are no comments on this title.

to post a comment.

Back to results

1 None
by Heck, Ansgar
2 [Large goiter--diagnosis and treatment].
by Heck, Ansgar
3 Parathyroid hormone independent hypercalcemia in adults.
by Bollerslev, Jens
4 MANAGEMENT OF ENDOCRINE DISEASE: Individualised management of acromegaly.
by Bollerslev, Jens
5 Treatment of acromegaly increases BMD but reduces trabecular bone score: a longitudinal study.
by Godang, Kristin
6 The Metabolic Risk in Patients Newly Diagnosed with Acromegaly Is Related to Fat Distribution and Circulating Adipokines and Improves after Treatment.
by Olarescu, Nicoleta C
7 Quantitative analyses of T2-weighted MRI as a potential marker for response to somatostatin analogs in newly diagnosed acromegaly.
by Heck, Ansgar
8 MRI T2 characteristics in somatotroph adenomas following somatostatin analog treatment in acromegaly.
by Heck, Ansgar
9 Adenoma granulation pattern correlates with clinical variables and effect of somatostatin analogue treatment in a large series of patients with acromegaly.
by Fougner, Stine Lyngvi
10 Alternative splicing of placental lactogen (CSH2) in somatotroph pituitary adenomas.
by Lekva, Tove
11 Intensity of pituitary adenoma on T2-weighted magnetic resonance imaging predicts the response to octreotide treatment in newly diagnosed acromegaly.
by Heck, Ansgar
12 Expression of SSTR2a, but not of SSTRs 1, 3, or 5 in somatotroph adenomas assessed by monoclonal antibodies was reduced by octreotide and correlated with the acute and long-term effects of octreotide.
by Casar-Borota, Olivera
13 Attenuated RORC expression in the presence of EMT progression in somatotroph adenomas following treatment with somatostatin analogs is associated with poor clinical recovery.
by Lekva, Tove
14 Targeting either GH or IGF-I during somatostatin analogue treatment in patients with acromegaly: a randomized multicentre study.
by Dal, Jakob
15 The effect of surgery on fat mass, lipid and glucose metabolism in mild primary hyperparathyroidism
by Godang, Kristin
16 Hip Structure Analyses in Acromegaly: Decrease of Cortical Bone Thickness After Treatment: A Longitudinal Cohort Study.
by Godang, Kristin
17 Epithelial splicing regulator protein 1 and alternative splicing in somatotroph adenomas.
by Lekva, Tove
18 Effect of Surgery Versus Observation: Skeletal 5-Year Outcomes in a Randomized Trial of Patients With Primary HPT (the SIPH Study).
by Lundstam, Karolina
19 Effects of parathyroidectomy versus observation on the development of vertebral fractures in mild primary hyperparathyroidism.
by Lundstam, Karolina
20 Insulin sensitivity, body composition and adipose depots following 12 w combined endurance and strength training in dysglycemic and normoglycemic sedentary men.
by Langleite, Torgrim Mikal